title: Severe Cardiac Complications of Shabu Use: An Emerging Drug in Europe.
authors.affiliation: Servicio de Cardiología, Institut Clínic Cardiovascular, Hospital Clínic, Universidad de Barcelona, Barcelona, Spain.
authors.forename: Margarida
authors.initials: M
authors.lastname: Pujol-López
authors.affiliation: Servicio de Cardiología, Institut Clínic Cardiovascular, Hospital Clínic, Universidad de Barcelona, Barcelona, Spain.
authors.forename: Luis
authors.initials: L
authors.lastname: Ortega-Paz
authors.affiliation: Servicio de Cardiología, Institut Clínic Cardiovascular, Hospital Clínic, Universidad de Barcelona, Barcelona, Spain.
authors.forename: Mercè
authors.initials: M
authors.lastname: Roqué
authors.affiliation: Servicio de Cardiología, Institut Clínic Cardiovascular, Hospital Clínic, Universidad de Barcelona, Barcelona, Spain. Electronic address: xbosch@clinic.ub.es.
authors.forename: Xavier
authors.initials: X
authors.lastname: Bosch
mesh_terms: D000328:Adult; D066126:Cardiotoxicity; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D005260:Female; D006331:Heart Diseases / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008297:Male; D008694:Methamphetamine / Q000009:adverse effects*; D008875:Middle Aged; D010679:Philippines / Q000453:epidemiology; D012307:Risk Factors; D015996:Survival Rate / Q000639:trends; D055815:Young Adult
chemical_list: D000697:Central Nervous System Stimulants; D008694:Methamphetamine